Epidermal growth factor alters silica nanoparticle uptake and improves gold-nanoparticle-mediated gene silencing in A549 cells

Introduction: Delivery of therapeutic nanoparticles (NPs) to cancer cells represents a promising approach for biomedical applications. A key challenge for nanotechnology translation from the bench to the bedside is the low amount of administered NPs dose that effectively enters target cells. To impr...

Full description

Bibliographic Details
Main Authors: Eva Susnik, Amelie Bazzoni, Patricia Taladriz-Blanco, Sandor Balog, Aura Maria Moreno-Echeverri, Christina Glaubitz, Beatriz Brito Oliveira, Daniela Ferreira, Pedro Viana Baptista, Alke Petri-Fink, Barbara Rothen-Rutishauser
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Nanotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnano.2023.1220514/full
_version_ 1797778008107384832
author Eva Susnik
Amelie Bazzoni
Patricia Taladriz-Blanco
Sandor Balog
Aura Maria Moreno-Echeverri
Christina Glaubitz
Beatriz Brito Oliveira
Daniela Ferreira
Pedro Viana Baptista
Alke Petri-Fink
Alke Petri-Fink
Barbara Rothen-Rutishauser
author_facet Eva Susnik
Amelie Bazzoni
Patricia Taladriz-Blanco
Sandor Balog
Aura Maria Moreno-Echeverri
Christina Glaubitz
Beatriz Brito Oliveira
Daniela Ferreira
Pedro Viana Baptista
Alke Petri-Fink
Alke Petri-Fink
Barbara Rothen-Rutishauser
author_sort Eva Susnik
collection DOAJ
description Introduction: Delivery of therapeutic nanoparticles (NPs) to cancer cells represents a promising approach for biomedical applications. A key challenge for nanotechnology translation from the bench to the bedside is the low amount of administered NPs dose that effectively enters target cells. To improve NPs delivery, several studies proposed NPs conjugation with ligands, which specifically deliver NPs to target cells via receptor binding. One such example is epidermal growth factor (EGF), a peptide involved in cell signaling pathways that control cell division by binding to epidermal growth factor receptor (EGFR). However, very few studies assessed the influence of EGF present in the cell environment, on the cellular uptake of NPs.Methods: We tested if the stimulation of EGFR-expressing lung carcinomacells A549 with EGF affects the uptake of 59 nm and 422 nm silica (SiO2) NPs. Additionally, we investigated whether the uptake enhancement can be achieved with gold NPs, suitable to downregulate the expression of cancer oncogene c-MYC.Results: Our findings show that EGF binding to its receptor results in receptor autophosphorylation and initiate signaling pathways, leading to enhanced endocytosis of 59 nm SiO2 NPs, but not 422 nm SiO2 NPs. Additionally, we demonstrated an enhanced gold (Au) NPs endocytosis and subsequently a higher downregulation of c-MYC.Discussion: These findings contribute to a better understanding of NPs uptake in the presence of EGF and that is a promising approach for improved NPs delivery.
first_indexed 2024-03-12T23:11:09Z
format Article
id doaj.art-028e2419615345e8b751c72a395a7988
institution Directory Open Access Journal
issn 2673-3013
language English
last_indexed 2024-03-12T23:11:09Z
publishDate 2023-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nanotechnology
spelling doaj.art-028e2419615345e8b751c72a395a79882023-07-18T00:58:24ZengFrontiers Media S.A.Frontiers in Nanotechnology2673-30132023-07-01510.3389/fnano.2023.12205141220514Epidermal growth factor alters silica nanoparticle uptake and improves gold-nanoparticle-mediated gene silencing in A549 cellsEva Susnik0Amelie Bazzoni1Patricia Taladriz-Blanco2Sandor Balog3Aura Maria Moreno-Echeverri4Christina Glaubitz5Beatriz Brito Oliveira6Daniela Ferreira7Pedro Viana Baptista8Alke Petri-Fink9Alke Petri-Fink10Barbara Rothen-Rutishauser11Adolphe Merkle Institute, University of Fribourg, Fribourg, SwitzerlandAdolphe Merkle Institute, University of Fribourg, Fribourg, SwitzerlandInternational Iberian Nanotechnology Laboratory, Braga, PortugalAdolphe Merkle Institute, University of Fribourg, Fribourg, SwitzerlandAdolphe Merkle Institute, University of Fribourg, Fribourg, SwitzerlandAdolphe Merkle Institute, University of Fribourg, Fribourg, Switzerlandi4HB, UCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Caparica, Portugali4HB, UCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Caparica, Portugali4HB, UCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Caparica, PortugalAdolphe Merkle Institute, University of Fribourg, Fribourg, SwitzerlandDepartment of Chemistry, University of Fribourg, Fribourg, SwitzerlandAdolphe Merkle Institute, University of Fribourg, Fribourg, SwitzerlandIntroduction: Delivery of therapeutic nanoparticles (NPs) to cancer cells represents a promising approach for biomedical applications. A key challenge for nanotechnology translation from the bench to the bedside is the low amount of administered NPs dose that effectively enters target cells. To improve NPs delivery, several studies proposed NPs conjugation with ligands, which specifically deliver NPs to target cells via receptor binding. One such example is epidermal growth factor (EGF), a peptide involved in cell signaling pathways that control cell division by binding to epidermal growth factor receptor (EGFR). However, very few studies assessed the influence of EGF present in the cell environment, on the cellular uptake of NPs.Methods: We tested if the stimulation of EGFR-expressing lung carcinomacells A549 with EGF affects the uptake of 59 nm and 422 nm silica (SiO2) NPs. Additionally, we investigated whether the uptake enhancement can be achieved with gold NPs, suitable to downregulate the expression of cancer oncogene c-MYC.Results: Our findings show that EGF binding to its receptor results in receptor autophosphorylation and initiate signaling pathways, leading to enhanced endocytosis of 59 nm SiO2 NPs, but not 422 nm SiO2 NPs. Additionally, we demonstrated an enhanced gold (Au) NPs endocytosis and subsequently a higher downregulation of c-MYC.Discussion: These findings contribute to a better understanding of NPs uptake in the presence of EGF and that is a promising approach for improved NPs delivery.https://www.frontiersin.org/articles/10.3389/fnano.2023.1220514/fullepidermal growth factornanoparticlessilicagoldendocytosismolecular mechanisms
spellingShingle Eva Susnik
Amelie Bazzoni
Patricia Taladriz-Blanco
Sandor Balog
Aura Maria Moreno-Echeverri
Christina Glaubitz
Beatriz Brito Oliveira
Daniela Ferreira
Pedro Viana Baptista
Alke Petri-Fink
Alke Petri-Fink
Barbara Rothen-Rutishauser
Epidermal growth factor alters silica nanoparticle uptake and improves gold-nanoparticle-mediated gene silencing in A549 cells
Frontiers in Nanotechnology
epidermal growth factor
nanoparticles
silica
gold
endocytosis
molecular mechanisms
title Epidermal growth factor alters silica nanoparticle uptake and improves gold-nanoparticle-mediated gene silencing in A549 cells
title_full Epidermal growth factor alters silica nanoparticle uptake and improves gold-nanoparticle-mediated gene silencing in A549 cells
title_fullStr Epidermal growth factor alters silica nanoparticle uptake and improves gold-nanoparticle-mediated gene silencing in A549 cells
title_full_unstemmed Epidermal growth factor alters silica nanoparticle uptake and improves gold-nanoparticle-mediated gene silencing in A549 cells
title_short Epidermal growth factor alters silica nanoparticle uptake and improves gold-nanoparticle-mediated gene silencing in A549 cells
title_sort epidermal growth factor alters silica nanoparticle uptake and improves gold nanoparticle mediated gene silencing in a549 cells
topic epidermal growth factor
nanoparticles
silica
gold
endocytosis
molecular mechanisms
url https://www.frontiersin.org/articles/10.3389/fnano.2023.1220514/full
work_keys_str_mv AT evasusnik epidermalgrowthfactoralterssilicananoparticleuptakeandimprovesgoldnanoparticlemediatedgenesilencingina549cells
AT ameliebazzoni epidermalgrowthfactoralterssilicananoparticleuptakeandimprovesgoldnanoparticlemediatedgenesilencingina549cells
AT patriciataladrizblanco epidermalgrowthfactoralterssilicananoparticleuptakeandimprovesgoldnanoparticlemediatedgenesilencingina549cells
AT sandorbalog epidermalgrowthfactoralterssilicananoparticleuptakeandimprovesgoldnanoparticlemediatedgenesilencingina549cells
AT auramariamorenoecheverri epidermalgrowthfactoralterssilicananoparticleuptakeandimprovesgoldnanoparticlemediatedgenesilencingina549cells
AT christinaglaubitz epidermalgrowthfactoralterssilicananoparticleuptakeandimprovesgoldnanoparticlemediatedgenesilencingina549cells
AT beatrizbritooliveira epidermalgrowthfactoralterssilicananoparticleuptakeandimprovesgoldnanoparticlemediatedgenesilencingina549cells
AT danielaferreira epidermalgrowthfactoralterssilicananoparticleuptakeandimprovesgoldnanoparticlemediatedgenesilencingina549cells
AT pedrovianabaptista epidermalgrowthfactoralterssilicananoparticleuptakeandimprovesgoldnanoparticlemediatedgenesilencingina549cells
AT alkepetrifink epidermalgrowthfactoralterssilicananoparticleuptakeandimprovesgoldnanoparticlemediatedgenesilencingina549cells
AT alkepetrifink epidermalgrowthfactoralterssilicananoparticleuptakeandimprovesgoldnanoparticlemediatedgenesilencingina549cells
AT barbararothenrutishauser epidermalgrowthfactoralterssilicananoparticleuptakeandimprovesgoldnanoparticlemediatedgenesilencingina549cells